Statements (14)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Boehringer_Ingelheim
|
| gptkbp:acquisitionYear |
2020
|
| gptkbp:country |
gptkb:Switzerland
|
| gptkbp:focus |
oncology
antibody-drug conjugates |
| gptkbp:foundedIn |
2012
|
| gptkbp:founder |
Ulf Grawunder
|
| gptkbp:headquartersLocation |
Basel
|
| https://www.w3.org/2000/01/rdf-schema#label |
NBE-Therapeutics
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:website |
https://www.nbe-therapeutics.com/
|
| gptkbp:bfsParent |
gptkb:Novo_Holdings
|
| gptkbp:bfsLayer |
7
|